Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel Tyson, Daniel González, Christine Park et al.|Frontiers in Pharmacology|2020Cited by 141
Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomesStephen J. Balevic, Daniel González, Daniel Weiner et al.|Lupus Science & Medicine|2022Cited by 24
Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation PatientsRobyn Konicki, J. Robert Powell, Daniel Weiner et al.|Clinical and Translational Science|2020Cited by 16
Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trialStephen J. Balevic, Daniel González, Rachel L. Randell et al.|Lupus Science & Medicine|2022Cited by 10
Indomethacin Pharmacokinetics and Pharmacodynamics in Pregnancies With Preterm Labor: The Need for Dose‐Ranging TrialsStephen J. Balevic, Erik Rytting, Daniel Weiner et al.|The Journal of Clinical Pharmacology|2024Cited by 4